2012-10-10T14:57:32-05:00 2011-06-30 PricewaterhouseCoopers LLP 2001 MARKET ST SUITE 1700 PHILADELPHIA PA 19103 990 2010-07-01 236296135 INSTITUTE FOR CANCER RESEARCH INST 2157282457 333 COTTMAN AVENUE PHILADELPHIA PA 191112497 THOMAS S ALBANESI JR 2012-10-09 true 2673303000 2010 2016-02-24 21:20:13Z X MICHAEL V SEIDEN MD PHD 333 COTTMAN AVENUE PHILADELPHIA PA 19111 25059900 false X WWW.FCCC.EDU X 1944 DE TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. 30 28 525 91 0 0 26510262 23123236 0 0 369406 1292884 703936 643780 27583604 25059900 312491 240176 0 0 19028214 24796609 0 0 0 14369457 7204699 33710162 32241484 -6126558 -7181584 83336426 79553596 55576709 57275787 27759717 22277809 X TO PREVAIL OVER CANCER, MARSHALING HEART AND MIND IN BOLD SCIENTIFIC DISCOVERY, PIONEERING PREVENTION AND COMPASSIONATE CARE. false false 21412682 240176 19088697 THE DIVISION OF BASIC SCIENCE IS RENOWNED WORLD-WIDE FOR ITS WORK IN UNDERSTANDING BOTH NORMAL AND ABNORMAL CELL GROWTH. SCIENTISTS ARE INVOLVED IN STUDIES OF GENES THAT CAUSE OR INHIBIT CANCER GROWTH, VIROLOGY, IMMUNOLOGY, CHEMICAL CARCINOGENS, CELL GROWTH AND INTERACTION AND GENE EXPRESSION. IN RECENT YEARS, RESEARCH HAS INCREASINGLY EMPHASIZED MOLECULAR ONCOLOGY AND GENETICS, AREAS WHICH BRIDGE ADVANCING KNOWLEDGE FROM THE LABORATORY WITH NEW CLINICAL APPROACHES. 6235884 7082016 THE RESEARCH FACILITIES HAVE BEEN STRUCTURED TO FULFILL THE NEEDS OF THE MULTI-DISCIPLINARY RESEARCH PROGRAMS AT FOX CHASE CANCER CENTER. THE FACILITIES HAVE BEEN DESIGNED TO ENHANCE ONGOING RESEARCH BY SUPPLYING INFORMATION, REAGENTS, AND TECHNICAL EXPERTISE THAT ARE NOT READILY AVAILABLE TO THE INDIVIDUAL INVESTIGATOR. 27648566 true false false true false false false false true true false true false true false false true false false false false false false false false false false true true false false false false false false false true false false false false false true true false false false true 0 0 true 525 true false false false false false false false false false false X 30 28 false true false false false false false true true false true true false true true true true true true true false NJ PA X THOMAS S ALBANESI JR CFO 2157282457 604 COTTMAN AVENUE CHELTENHAM PA 19012 David G Marshall 1.0 X X 0 0 0 Louis E Della Penna Sr 1.0 X X 0 0 0 W Thacher Brown 1.0 X X 0 0 0 Margot Keith 1.0 X X 0 0 0 Peter McCausland 1.0 X X 0 0 0 Donald E Morel Jr PhD 1.0 X X 0 0 0 William J Avery 1.0 X X 0 0 0 Michael V Seiden MD PhD 10.0 X X 0 502102 33791 THOMAS W HOFMANN 1.0 X X 0 0 0 G Morris Dorrance Jr 1.0 X 0 0 0 The Honorable Dwight Evans 1.0 X 0 0 0 Edward A Glickman 1.0 X 0 0 0 Michael J Heller Esq 1.0 X 0 0 0 JOHN W CONWAY JR 1.0 X 0 0 0 Lawrence T Hoyle Jr Esq 1.0 X 0 0 0 Geoffrey Kent 1.0 X 0 0 0 Philip E Lippincott 1.0 X 0 0 0 William G Little 1.0 X 0 0 0 Jill Michal 1.0 X 0 0 0 Jane G Pepper 1.0 X 0 0 0 Edward J Roach 1.0 X 0 0 0 Thomas Shenk PhD 1.0 X 0 0 0 Lindy Snider 1.0 X 0 0 0 Pamela Strisofsky 1.0 X 0 0 0 William Stulginsky 1.0 X 0 0 0 Thomas R Tritton PhD 1.0 X 0 0 0 Kenneth E Weg 1.0 X 0 0 0 Yoram Wind PhD 1.0 X 0 0 0 Zane Wolf PhD 1.0 X 0 0 0 Debra Sniger 1.0 X 0 0 0 J Robert Beck MD 10.0 X 0 360250 22002 Jonathan Chernoff MD PhD 25.0 X 314570 0 21898 Paul F Engstrom MD 5.0 X 0 416110 35442 Joseph F Hediger 10.0 X 0 337805 23580 Thomas S Albanesi Jr 5.0 X 0 0 0 Robert Wilkens 10.0 X 0 268519 4858 Susan H Tofani 5.0 X 0 300250 15288 Gary J Weyhmuller 15.0 X 0 300250 34818 MARK HERBERS 10.0 X 0 0 0 Jeffrey Boyd PhD 25.0 X 0 355929 32408 ERICA A GOLEMIS PhD 25.0 X 163175 0 30159 ANNA M SKALKA PHD 25.0 X 0 295250 29443 HARRY ROZMIAREK 40.0 X 199145 0 9440 JOHN TAYLOR PhD 40.0 X 180441 0 8767 WILLIAM S MASON PhD 40.0 X 167255 0 24908 RICHARD R HARDY PhD 40.0 X 170892 0 28368 HEINRICH RODER PhD 40.0 X 157806 0 28839 1353284 3136465 384009 29 false true true EWING COLE 100 NORTH 6TH STREET PHILADELPHIA PA 19106 CONSTRUCTION 1401817 MR ROSE CONSTRUCTION INC 3001 CASTOR AVENUE PHILADELPHIA PA 19103 CONSTRUCTION 852286 SODEXO INC ASSOCIATES 100 NORTH 6TH STREET PHILADELPHIA PA 19106 FOOD SERVICES 629244 NUTRITION MANAGEMENT SERVICES INC BOX 725 KIMBERTON ROAD KIMBERTON PA 19442 FOOD SERVICE 287954 ELSEVIER PO BOX 7247 PHILADELPHIA PA 19170 ONLINE PERIODICALS 187471 9 22078116 1045120 23123236 0 1292884 171060 0 643780 643780 0 0 0 0 0 25059900 0 814840 0 240176 240176 0 0 1229202 1229202 0 16760598 15084538 1676060 0 272272 247768 24504 6534537 6403846 130691 0 0 0 0 0 0 0 292179 70123 222056 11272 11272 759717 83569 676148 784400 415732 368668 0 4304106 3357203 946903 192279 178819 13460 0 271386 244247 27139 859553 661856 197697 -10866510 -9388657 -1477853 6472397 5501537 970860 119032 71419 47613 PURCHASED SERVICES 4004888 3235916 768972 32241484 27648566 4592918 0 3116614 2365615 1728420 2094544 -10751685 1957156 1748938 136739693 77178791 61587030 59560902 3161294 3660479 16967984 18862337 -5548196 2378590 83336426 79553596 8596353 6462138 1562359 1469267 32635066 35159293 12782931 14185089 55576709 57275787 X 12460175 4407424 374094 1055805 14925448 16814580 27759717 22277809 83336426 79553596 X -7181584 1699676 X false true true X true true X AMERICAN ONCOLOGIC HOSPITAL PHILADELPHIA PA X 11615 61948 11615 61948 32229869 342051136 32241484 342113084 1000000 1000000 250000 250000 1000000 1000000 1000000 1000000 4000000 6000000 57747 157246 50284 61948 327225 250000 250000 250000 250000 1000000 1500000 0 0 0 0 0 PART I-A LINE 1 MANAGEMENT HAS DIRECT CONTACT WITH LEGISLATORS, THEIR STAFFS, AND GOVERMENT OFFICIALS TO ADVOCATE THE CENTER'S POSITION ON KEY ISSUES AFFECTING THE CENTER. FREQUENTLY, THESE CONTACTS ARE MADE TO EDUCATE THE APPROPRIATE REPRESENTATIVE OR OFFICIAL ON THE IMPLICATIONS OF SPECIFIC POLICY/LEGISLATION ON THE INDUSTURY IN GENERAL AND/OR IMPLICATIONS TO FOX CHASE. AT THE FEDERAL LEVEL, DURING FY 2011, THE CENTER ADVOCATED FOR INCREASED MEDICARE REIMBURSEMENT UNDER THE CANCER CENTER RULES AND ADVOCATED FOR INCREASED RESEARCH FUNDING FOR THE NIH AND NCI. MANAGEMENT ALSO PROVIDED INPUT ON VARIOUS ISSUES INCLUDING HEALTH CARE REFORM AND IMPORTANT ISSUES SUCH AS DRUG SHORTAGES LEGISLATION. ADDITIONALLY, TO ASSIST THE CENTER OBTAIN NEEDED FUNDING FOR CUTTING EDGE TECHNOLOGIES AND RESOURCES USED BY THE SCIENTIFIC AND CLINICAL FACULTY, THE CENTER SUBMITTED FEDERAL GRANTS THROUGH THE APPROPRIATION MECHANISMS. AT THE STATE LEVEL, MANAGEMENT ADVOCATED FOR THE SUSTAINED USE OF TOBACCO FUNDS TO SUPPORT THE VARIOUS CANCER PROGRAMS IN THE COMMONWEALTH. THIS FUNDING IS CENTRAL TO THE PROGRAMS CONDUCTED BY THE CENTER IN CANCER RESEARCH, PREVENTION, SCREENING AND TREATMENT. MANAGEMENT ALSO MET WITH VARIOUS STATE REPRESENTATIVES TO OBTAIN FUNDING FOR CAPITAL AND OPERATING PROGRAMS UNDER THE VARIOUS APPROPRIATION MECHANISMS TO SUPPORT ECONOMIC DEVELOPMENT OPPORTUNITIES. 3161294 11573 750380 262768 3660479 3552556 1000 309714 76976 625000 3161294 8093846 279853 -1518099 16591 3286453 3552556 0.01200 0.98300 0.00400 true true true 61164 61164 82168899 57543651 24625248 507701 507701 28519947 16577855 11942092 25481982 2549584 22932397 59560901 OTHER INVESTMENTS 4830000 F FUNDS HELD IN TRUST 14032337 F 18862337 0 SERVICE PAY 289000 LONG TERM WORKERS COMPENSATION 3323741 POST RETIREMENT BENEFITS 1518972 ENVIRONMENTAL LIABILITIES 586614 CAFETERIA IMPROVEMENTS 1575000 SECURITY DEPOSIT 4000 INTEREST RATE SWAPS 6887762 14185089 PART V LINE 4 APPOINTMENT TO AN ENDOWED CHAIR REWARDS A SCIENTIST'S PROFESSIONAL CONTRIBUTIONS, RECOGNIZES THE VALUE OF HIS OR HER RESEARCH ENDEAVORS AND SAFEGUARDS THE FUNDING NEEDED TO CONTINUE THESE PIONEERING INQUIRIES. THOSE WHO SUPPORT A CHAIR ENDOWMENT BECOME VITAL PARTNERS IN OUR SCIENTIST GROUNDBREAKING, LIFESAVING DISCOVERIES. ENDOWING AND NAMING A CHAIR PROVIDES THE OPPORTUNITY TO HONOR A LOVED ONE WITH A MEMORIAL THAT WILL LAST FOR MANY, MANY YEARS. ENDOWED CHAIRS PROVIDE A STEADY AND PREDICTABLE FLOW OF FUNDS IN PERPETUITY, ALLOWING THE INSTITUTIONS TO STRENGTHEN THE QUALITY OF ITS PROGRAMS AND SERVICES BEYOND LEVELS THAT OTHER FUNDING SOURCES ALONE COULD SUPPORT. BOARD DESIGNATED FUNDS GIVE THE INSTITUTE FOR CANCER RESEARCH THE FLEXIBLE FUNDING TO INITIATE NEW RESEARCH PROGRAMS FOR THE PREVENTION, DETECTION, AND TREATMENT OF CANCER. THE FUNDS ASSIST PATIENTS AND THEIR FAMILIES RECEIVE THE BEST SUPPORT AND PROVIDE IMPORTANT SERVICES TO THE COMMUNITY. true ICR POSTDOCTORAL FELLOWSHIP 1 22255 0 FMV N/A REIMANN FELLOWSHIP 2 2680 0 FMV N/A WILLIAM J AVERY ENDOWED POSTDOCTORAL FELLOWSHIP 2 42877 0 FMV N/A BOARD OF ASSOCIATES PLAIN & FANCY FELLOWSHIP 2 34285 0 N/A FMV ELIZABETH KNIGHT PATTERSON FELLOWSHIP 2 54169 0 FMV N/A LAWRENCE GREENWALD POSTDOCTORAL FELLOWSHIP 2 41575 0 FMV N/A GREENBERG FELLOWSHIP 2 14906 0 FMV N/A F.M. KIRBY POSTDOCTORAL FELLOWSHIP 1 27429 0 FMV N/A PART I LINE 2 THE APPOINTMENTS FOR POSTDOCTORAL TRAINING CAN BEGIN UPON COMPLETION OF ALL REBUIREMENTS FOR THE DOCTORAL DEGREE. THOSE APPOINTED UNDER THE TRAINING GRANTS FROM NCI MAY HAVE NO MORE THAN THREE YEARS OF POSTDOCTORAL EXPERIENCE AND MUST BE A US CITIZEN OR PERMANENT RESIDENCE VISA. THE PROGRAMS EMPHASIZE MENTORED RESEARCH SUPERVISION, MULTIDISCIPLINARY SEMINARS, CLINICAL ROUNDS, WORKSHOPS IN RESEARCH TECHNOLOGY AND IN SCIENTIFIC WRITING, GRANT AND MANUSCRIPT CRITICAL REVIEW. X X X X true false false false false false false false false Michael V Seiden MD PhD 0 472500 0 250 0 29352 0 13946 0 19845 0 535893 0 0 J Robert Beck MD 0 339900 0 20350 0 0 0 11900 0 10102 0 382252 0 0 Jonathan Chernoff MD PhD 273462 0 29962 0 11146 0 11473 0 10425 0 336468 0 0 0 Paul F Engstrom MD 0 414060 0 2050 0 0 0 13064 0 22378 0 451552 0 0 Joseph F Hediger 0 236538 0 13358 0 87909 0 8069 0 15511 0 361385 0 0 Robert Wilkens 0 250000 0 18519 0 0 0 2308 0 2550 0 273377 0 0 Susan H Tofani 0 300000 0 250 0 0 0 10608 0 4680 0 315538 0 0 Gary J Weyhmuller 0 300000 0 250 0 0 0 10608 0 24210 0 335068 0 0 Jeffrey Boyd PhD 0 350000 0 250 0 5679 0 11685 0 20723 0 388337 0 0 HARRY ROZMIAREK 198895 0 250 0 0 0 7650 0 1790 0 208585 0 0 0 JOHN TAYLOR PhD 180191 0 250 0 0 0 6931 0 1836 0 189208 0 0 0 WILLIAM S MASON PhD 167005 0 250 0 0 0 6423 0 18485 0 192163 0 0 0 RICHARD R HARDY PhD 156042 0 7750 0 7100 0 6290 0 22078 0 199260 0 0 0 ERICA A GOLEMIS PhD 155425 0 7750 0 0 0 6281 0 23878 0 193334 0 0 0 HEINRICH RODER PhD 157556 0 250 0 0 0 6060 0 22779 0 186645 0 0 0 ANNA M SKALKA PHD 0 295000 0 250 0 0 0 10500 0 18943 0 324693 0 0 PETER MCCAUSLAND - AIRGAS BOARD OF DIRECTOR 106390 SEE PART V false FORM 990, SCHEDULE L, PART IV THE INSTITUTE FOR CANCER RESEARCH CONDUCTS BUSINESS WITH AIRGAS ON A ROUTINE BASIS. AIRGAS IS A DISTRIBUTOR OF SPECIALIZED GASES. PETER MCCAUSLAND IS THE CEO AND A MAJOR SHAREHOLDER OF AIRGAS AND A MEMBER OF OUR BOARD OF DIRECTORS. THE TOTAL EXPENSES INCURRED DURING FY 2011 RELATED TO AIRGAS WERE $106,390. FORM 990 PART I, LINE 8 CONTRIBUTIONS REPORTED IN PART I, LINE 8 ARE ALLOCATED TO FOX CHASE CANCER CENTER, A RELATED ORGANIZATION, AND ARE INCLUDED ON FORM 990, SCHEDULE B, LIST OF CONTRIBUTORS. FORM 990 PART VI SECTION A LINE 3 MARK HERBERS, AN EMPLOYEE OF FTI CONSULTING, WAS IN THE CAPACITY OF INTERIM CHIEF FINANCIAL OFFICER DURING FISCAL YEAR 2011 FROM OCTOBER 2010 UNTIL APRIL 2011. FTI CONSULTING RECEIVED COMPENSATION IN CONNECTION WITH SERVICES PROVIDED BY MARK HERBERS TO THE ORGANIZATION, THE DETAILS OF WHICH ARE DISCLOSED IN SCHEDULE O. FORM 990 PART VI SECTION B LINE 11A THE FORM 990 IS PREPARED BY PWC AND REVIEWED BY SEVERAL MEMBERS OF THE FINANCE DEPARTMENT INCLUDING BOTH THE VICE PRESIDENT - FINANCE AND THE SR. VICE PRESIDENT - FINANCE CFO, MEMBERS OF THE SENIOR LEADERSHIP COMMITTEE AND THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS IS PROVIDED A COPY OF THE FORM 990 AT THEIR NEXT BOARD MEETING. FORM 990 PART VI SECTION B LINE 12C IN THE CASE OF POTENTIAL CONFLICT OF INTEREST OR COMMITMENT, THE PRESIDENT OF FCCC SHALL BE RESPONSIBLE FOR ADMINISTERING ALL MATTERS. ALL DISCLOSURES SHALL BE KEPT CONFIDENTIAL, IN A SEPARATE FILE UNDER THE CONTROL OF THE OFFICE OF THE PRESIDENT. THEY SHALL NOT BE MADE PART OF ANY PERSONNEL RECORD OR THE BASIS FOR ANY REVIEW OF THE PERFORMANCE OF THE INDIVIDUAL STAFF MEMBER. ACCESS TO THESE RECORD SHALL BE MADE AVAILABLE ONLY TO BOARD MEMBERS, THE PRESIDENT OR HIS DESIGNEE OR A PROPERLY AUTHORIZED GOVERNMENTAL BODY, ACTING UNDER STATUTORY OR REGULATORY AUTHORITY. RECORD WILL BE MAINTAINED FOR THREE YEARS UNLESS THE MATERIALS ARE SUBJECT TO GOVERNMENTAL ACTION. DISCLOSURES SHALL BE REQUIRED OF ALL STAFF AND BOARD MEMBERS AS FOLLOWS: BY BOARD MEMBERS: ALL BOARD MEMBERS OF FCCC SHALL BE REQUIRED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM AT THE TIME OF APPOINTMENT, ANNUALLY AND WHENEVER A NEW POTENTIAL CONFLICT ARISES. BY EMPLOYEES: ALL SCIENTISTS, PHYSICIANS AND ADMINISTRATIVE EMPLOYEES AT THE MANAGEMENT LEVEL AND ABOVE OF FCCC SHALL BE REQUIRED TO COMPLETE A CONFLICT OF INTEREST FORM AT THE TIME OF EMPLOYMENT, ANNUALLY AND WHENEVER A NEW POTENTIAL CONFLICT ARISES AND SUBMIT SUCH DISCLOSURE FORMS TO THE CHIEF ACADEMIC OFFICER OR HIS DESIGNEE. BY CONSULTANTS AND SUBCONTRACTORS: CONSULTANTS AND SUBCONTRACTORS SHALL CERTIFY TO FCCC THAT THEY ARE NOT IN A POSITION TO INFLUENCE CENTER BUSINESS, RESEARCH OR OTHER DECISIONS IN WAYS THAT COULD LEAD TO ANY FORM OF PERSONAL GAIN FROM THEM OR THEIR FAMILY OR GIVE IMPROPER ADVANTAGE TO OTHERS TO THE CENTER'S DETRIMENT. FORM 990 PART VI SECTION B LINE 15B THE ORGANIZATION'S COMPENSATION POLICY FOR THE POSITIONS OF CEO, EXECUTIVE DIRECTORS, SENIOR MANAGEMENT, OFFICERS AND OR KEY EMPLOYEES IS TO UTILIZE A NATIONAL SURVEY FACILITY FOR COMPENSATION INFORMATION. ANNUALLY, IT IS REVIEWED BY THE ORGANIZATION'S EXECUTIVE COMMITTEE AS WELL AS THE FULL BOARD FOR APPROVAL. FORM 990 PART VI SECTION C LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC WHEN REQUESTED. FORM 990, PART VII CERTAIN OFFICERS AND KEY EMPLOYEES OF FOX CHASE CANCER CENTER AND AFFILIATES ALSO DEVOTE SIGNIFICANT TIME EACH WEEK TO OTHER RELATED ORGANIZATIONS AS FOLLOWS: Michael V. Seiden, MD, Ph.D. - 25 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 10 hours to Health Services of Fox Chase Cancer Center - 10 hours to Institute For Cancer Research - 5 hours to Fox Chase Network Paul Engstrom, MD - 20 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 10 hours to Health Services of Fox Chase Cancer Center - 5 hours to Institute For Cancer Research - 15 hours to Fox Chase Network Thomas S. Albanesi, Jr. - 20 hours to Fox Chase Cancer Center - 15 hours to American Oncologic Hospital - 15 hours to Health Services of Fox Chase Cancer Center - 5 hours to Institute For Cancer Research - 5 hours to FCCC Select J. Robert Beck, MD - 25 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 10 hours to Health Services of Fox Chase Cancer Center - 10 hours to Institute For Cancer Research - 5 hours to Fox Chase Network Jonathan Chernoff, MD, Ph.D. - 25 hours to Fox Chase Cancer Center - 5 hours to American Oncologic Hospital - 5 hours to Health Services of Fox Chase Cancer Center - 25 hours to Institute For Cancer Research Susan H. Tofani - 10 hours to Fox Chase Cancer Center - 15 hours to American Oncologic Hospital - 15 hours to Health Services of Fox Chase Cancer Center - 5 hours to Institute For Cancer Research - 15 hours to Fox Chase Network Gary J. Weyhmuller - 20 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 5 hours to Health Services of Fox Chase Cancer Center - 15 hours to Institute For Cancer Research - 5 hours to Fox Chase Network - 5 hours to FCCC Select Robert Wilkens - 25 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 5 hours to Health Services of Fox Chase Cancer Center - 10 hours to Institute For Cancer Research Joseph Hediger - 10 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 10 hours to Health Services of Fox Chase Cancer Center - 10 hours to Institute For Cancer Research - 5 hours to Fox Chase Network Mark Herbers - 20 hours to Fox Chase Cancer Center - 10 hours to American Oncologic Hospital - 10 hours to Health Services of Fox Chase Cancer Center - 10 hours to Institute For Cancer Research Anna Marie Skalka, Ph.D. - 25 hours to Institute for Cancer Research - 25 hours to Fox Chase Cancer Center Erica A. Golemis, Ph.D. - 25 hours to Institute for Cancer Research - 25 hours to Fox Chase Cancer Center Jeffrey Boyd, Ph.D. - 25 hours to Institute for Cancer Research - 25 hours to Fox Chase Cancer Center FORM 990, PART VII MARK HERBERS WAS IN THE CAPACITY OF INTERIM CFO DURING FISCAL 2011 WHILE EMPLOYED BY FTI CONSULTING. INDIVIDUAL COMPENSATION IS NOT AVAILABLE FROM FTI. IN CONNECTION WITH SERVICES PROVIDED BY MARK HERBERS TO THE ORGANIZATION FTI WAS PAID $393,139 BY FOX CHASE CANCER CENTER, AN AFFILIATE OF THE INSTITUTE FOR CANCER RESEARCH. FORM 990, PART XI TRANSFERS TO AFFILIATES 1,582,237 UNREALIZED GAINS 141,888 INCREASE IN POST RETIREMENT BENEFITS (24,449) ___________ TOTAL 1,699,676 FOX CHASE CANCER CENTER 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232003072 RESEARCH DE 501(C)(3) 4 NA AMERICAN ONCOLOGIC HOSPITAL 333 COTTMAN AVENUE PHILADELPHIA PA 19111 231352156 PATIENT CARE PA 501(C)(3) 3 NA HEALTH SERVICES OF FOX CHASE CANCER CENT 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232328543 PATIENT CARE PA 501(C)(3) 3 NA FOX CHASE NETWORK 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232467337 CLINICAL SVCS PA 501(C)(3) 11B FCCC FCCC SELECT 76 ST PAUL STREET BURLINGTON VT 05401 020597423 CAPTIVE INSUR VT 501(C)(3) 11A AOH FOX CHASE LIMITED 333 COTTMAN AVENUE PHILADELPHIA PA 19111 232396731 MEDICAL SERVI PA NA C CORP 0 0 0.00000 false false true false false false false false false true false false false false false false true true FOX CHASE CANCER CENTER Q 1391700 FOX CHASE CANCER CENTER R 3071176 AMERICAN ONCOLOGIC HOSPITAL R 1621727 FOX CHASE CANCER CENTER C 1582236 AMERICAN ONCOLOGIC HOSPITAL J 6484822 HEALTH SERVICES OF FOX CHASE CANCER CENTER J 1080491